Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience

Background: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 10%. Irreversible electroporation (IRE), a non-thermal ablative technique, may improve outcomes in locally advanced (LAPC) and borderline resectable pancreatic cancer (BRPC). This multi-center re...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Bart Hendrikx, Eline-Alice Brys, Alexandra Dili, Thomas Apers, Vera Hartman, Martin Brichard, Filip Gryspeerdt, Claude Bertrand, Geert Roeyen, Frederik Berrevoet
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2025-10-01
Cyfres:	Current Oncology
Pynciau:	pancreatic cancer irreversible electroporation margin accentuation tumor ablation outcomes
Mynediad Ar-lein:	https://www.mdpi.com/1718-7729/32/10/574
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!